Retension Pharmaceuticals, Inc. (RTSN)

Retension Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Retension Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-	-	0.00
Debt / EBITDA Ratio	-	-	0.00
Debt / FCF Ratio	-	-	0.00
Net Debt / Equity Ratio	-	2.43	4.74
Net Debt / EBITDA Ratio	-	2.75	3.61
Net Debt / FCF Ratio	-	2.43	4.66
Quick Ratio	4.69	20.72	29.55
Return on Equity (ROE)	80.02%	80.96%	110.60%
Return on Assets (ROA)	-	-29.38%	-22.82%
Return on Invested Capital (ROIC)	-	-48.07%	-28.19%
Return on Capital Employed (ROCE)	436.75%	-33.51%	-28.00%